Nu Skin Enterprises ( (NUS) ) has released its Q1 earnings. Here is a breakdown of the information Nu Skin Enterprises presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nu Skin Enterprises Inc. is a global beauty and wellness company that operates in nearly 50 markets worldwide, offering a range of personal care, nutrition, and anti-aging products through its dynamic affiliate platform.
In its first quarter of 2025, Nu Skin Enterprises reported revenue at the high end of its guidance range, despite a decline compared to the previous year. The company achieved a revenue of $364.5 million, marking a 12.7% decrease from the prior-year quarter, with a notable foreign exchange impact. Earnings per share stood at $2.14, significantly higher than the previous year’s loss, driven by a gain from the sale of Mavely.
Key financial metrics revealed a decrease in gross margin to 67.8% and a reduction in selling expenses to 32.5%. The company also reported a substantial gain on the sale of Mavely, contributing to a net income of $107.5 million. Despite challenges in consumer demand for premium beauty products, Nu Skin saw growth in Latin America and its Rhyz manufacturing segment. The company is preparing for the launch of its Prysm iO wellness device and expansion into the Indian market.
Looking ahead, Nu Skin Enterprises remains focused on improving margins and expanding its market presence. The company projects second-quarter revenue between $355 million and $390 million, with earnings per share expected to range from $0.20 to $0.30. Despite macroeconomic uncertainties, Nu Skin maintains its adjusted annual guidance, emphasizing cost efficiency and strategic growth initiatives.